BGM earnings date and last-quarter result: P/E -1.41. Updated 2026-07-23.
BGM Group (BGM) Research Hub
BGM Group (BGM) trades on NASDAQ, CN in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-10-26, shares last closed at 8.4 USD (+7.01%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.41, market cap 0.06B. This hub links to the full technical, earnings and options research available for BGM.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, CN |
| Last close | 8.4 USD (+7.01%) |
| 52-week range | 0.23 USD – 10.8 USD |
| Trend regime | Range |
| 14-day RSI | 40.2 (Bearish) |
| Trailing P/E | -1.41 |
| Market cap | 0.06B |
| Dividend yield | 0.00% |
Available research for BGM
Covered Call on BGM: how it works, illustrative setup around the real 8.4 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BGM: how it works, illustrative setup around the real 8.4 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BGM: how it works, illustrative setup around the real 8.4 USD price, max profit/loss, breakeven and when to use it. Educational.
BGM technical analysis: range, last 8.4 USD, RSI 40.2, 52w range 0.23 USD–10.8 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is BGM in?
BGM Group (BGM) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, CN.
Is BGM in an uptrend or downtrend?
As of 2026-10-26, BGM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BGM's trailing P/E ratio?
BGM's trailing P/E is -1.41, with a market cap of 0.06B. See the earnings research page for full valuation detail.